Additional file 2: Table S1. of Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy

Autor:	Agrawal, Shruti, Feng, Yan, Roy, Amit, Kollia, Georgia, Lestini, Brian
Rok vydání:	2016
DOI:	10.6084/m9.figshare.c.3600212_d6
Popis:	Baseline patient characteristics from CA209-003 in all treated patients. (DOCX 17Â kb)
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::014b7583c4074f05ca6a169e9d905dfb Zobrazit plný text záznamu